Skip to content
Wenlo
Sign in
← Markets

Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. (ACRS) — Form 424B5: Prospectus

424B5ACRSFiled Oct 27, 2026, 1:15 PM ET

About this filing

Aclaris Therapeutics, Inc. (ACRS) filed Form 424B5 (prospectus) with the SEC on Oct 27, 2026.

Key facts

Document
424B5

More ACRS filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.